Skip to main content
Top
Published in: BMC Gastroenterology 1/2008

Open Access 01-12-2008 | Research article

Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study

Authors: Anders Eriksson, Carl-Fredrik Flach, Anders Lindgren, Eva Kvifors, Stefan Lange

Published in: BMC Gastroenterology | Issue 1/2008

Login to get access

Abstract

Background

The cause and pathophysiology of ulcerative colitis are both mainly unknown. We have previously used whole-genome microarray technique on biopsies obtained from patients with ulcerative colitis to identifiy 5 changed mucosal transcripts. The aim of this study was to compare mucosal expressions of these five transcripts in ulcerative colitis patients vs. controls, along with the transcript expression in relation to the clinical ulcerative colitis status.

Methods

Colonic mucosal specimens from rectum and caecum were taken at ambulatory colonoscopy from ulcerative colitis patients (n = 49) with defined inflammatory activity and disease extension, and from controls (n = 67) without inflammatory bowel disease. The five mucosal transcripts aldolase B, elafin, MST-1, simNIPhom and SLC6A14 were analyzed using quantitative real-time PCR.

Results

Significant transcript differences in the rectal mucosa for all five transcripts were demonstrated in ulcerative colitis patients compared to controls. The grade of transcript expression was related to the clinical disease activity.

Conclusion

The five gene transcripts were changed in patients with ulcerative colitis, and were related to the disease activity. The known biological function of some of the transcripts may contribute to the inflammatory features and indicate a possible role of microbes in ulcerative colitis. The findings may also contribute to our pathophysiological understanding of ulcerative colitis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115: 182-205. 10.1016/S0016-5085(98)70381-6.CrossRefPubMed Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115: 182-205. 10.1016/S0016-5085(98)70381-6.CrossRefPubMed
2.
go back to reference Macdonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science. 2005, 307: 1920-1925. 10.1126/science.1106442.CrossRefPubMed Macdonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science. 2005, 307: 1920-1925. 10.1126/science.1106442.CrossRefPubMed
3.
go back to reference Ekbom A, Helmick C, Zack M, Adami HO: The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991, 100: 350-358.CrossRefPubMed Ekbom A, Helmick C, Zack M, Adami HO: The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991, 100: 350-358.CrossRefPubMed
4.
go back to reference Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N: Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996, 31: 362-366. 10.3109/00365529609006411.CrossRefPubMed Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N: Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996, 31: 362-366. 10.3109/00365529609006411.CrossRefPubMed
5.
go back to reference Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT: Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002. Eur J Gastroenterol Hepatol. 2006, 18: 601-6. 10.1097/00042737-200606000-00005.CrossRefPubMed Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT: Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002. Eur J Gastroenterol Hepatol. 2006, 18: 601-6. 10.1097/00042737-200606000-00005.CrossRefPubMed
6.
go back to reference Kucharzik T, Maaser C, Lugering A, Kagnoff M, Mayer L, Targan S, Domschke W: Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006, 12: 1068-83. 10.1097/01.mib.0000235827.21778.d5.CrossRefPubMed Kucharzik T, Maaser C, Lugering A, Kagnoff M, Mayer L, Targan S, Domschke W: Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006, 12: 1068-83. 10.1097/01.mib.0000235827.21778.d5.CrossRefPubMed
7.
go back to reference Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP: Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996, 14: 199-202. 10.1038/ng1096-199.CrossRefPubMed Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP: Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996, 14: 199-202. 10.1038/ng1096-199.CrossRefPubMed
8.
go back to reference Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003, 124: 26-33. 10.1053/gast.2003.50010.CrossRefPubMed Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003, 124: 26-33. 10.1053/gast.2003.50010.CrossRefPubMed
9.
go back to reference Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001, 10: 445-456. 10.1093/hmg/10.5.445. [9]CrossRefPubMed Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001, 10: 445-456. 10.1093/hmg/10.5.445. [9]CrossRefPubMed
10.
go back to reference Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP: Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997, 112: 1845-53. 10.1053/gast.1997.v112.pm9178675.CrossRefPubMed Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP: Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997, 112: 1845-53. 10.1053/gast.1997.v112.pm9178675.CrossRefPubMed
11.
go back to reference Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, Gurbuz Y, Eickhoff H, Kloppel G, Lehrach H, Mellgard B, Costello CM, Schreiber S: A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics. 2004, 16: 361-370. 10.1152/physiolgenomics.00080.2003.PubMed Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, Gurbuz Y, Eickhoff H, Kloppel G, Lehrach H, Mellgard B, Costello CM, Schreiber S: A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics. 2004, 16: 361-370. 10.1152/physiolgenomics.00080.2003.PubMed
12.
go back to reference Tan PK, Downey TJ, Spitznagel EL, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC: Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 2003, 31: 5676-5684. 10.1093/nar/gkg763.CrossRefPubMedPubMedCentral Tan PK, Downey TJ, Spitznagel EL, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC: Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 2003, 31: 5676-5684. 10.1093/nar/gkg763.CrossRefPubMedPubMedCentral
13.
go back to reference Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA: Analyzis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 2000, 4: 1-11.PubMed Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA: Analyzis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 2000, 4: 1-11.PubMed
14.
go back to reference Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lönnroth I: Detection of elafin as a candidate marker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis. 2006, 12: 837-847. 10.1097/01.mib.0000232469.23574.11.CrossRefPubMed Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lönnroth I: Detection of elafin as a candidate marker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis. 2006, 12: 837-847. 10.1097/01.mib.0000232469.23574.11.CrossRefPubMed
15.
go back to reference Sloan JL, Mager S: Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem. 1999, 274: 23740-23745. 10.1074/jbc.274.34.23740.CrossRefPubMed Sloan JL, Mager S: Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem. 1999, 274: 23740-23745. 10.1074/jbc.274.34.23740.CrossRefPubMed
16.
go back to reference Wachsmuth ED: Differentiation of epithelial cells in human jejunum: localization and quantification of aminopeptidase, alkaline phosphatase and aldolase isozymes in tissue sections. Histochemistry. 1976, 48: 101-109. 10.1007/BF00494548.CrossRefPubMed Wachsmuth ED: Differentiation of epithelial cells in human jejunum: localization and quantification of aminopeptidase, alkaline phosphatase and aldolase isozymes in tissue sections. Histochemistry. 1976, 48: 101-109. 10.1007/BF00494548.CrossRefPubMed
17.
go back to reference Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM: Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452: 309-313. 10.1016/S0014-5793(99)00670-5.CrossRefPubMed Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM: Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452: 309-313. 10.1016/S0014-5793(99)00670-5.CrossRefPubMed
18.
go back to reference Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J: Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol. 2007, 81: 907-915. 10.1189/jlb.0906581.CrossRefPubMed Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J: Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol. 2007, 81: 907-915. 10.1189/jlb.0906581.CrossRefPubMed
19.
go back to reference Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Pena AS, Ridell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF: Toward an integrated clinical, molecular and serologic classification of inflammatory bowel disease: Report from a working Party of the 2005 Montreal World congress of gastroenterology. Can J Gastroenterology. 2005, 19 (suppl A): 5-36.CrossRef Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Pena AS, Ridell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF: Toward an integrated clinical, molecular and serologic classification of inflammatory bowel disease: Report from a working Party of the 2005 Montreal World congress of gastroenterology. Can J Gastroenterology. 2005, 19 (suppl A): 5-36.CrossRef
20.
go back to reference Flach CF, Lange S, Jennische E, Lönnroth I: Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa. FEBS Lett. 2004, 561: 122-126. 10.1016/S0014-5793(04)00139-5.CrossRefPubMed Flach CF, Lange S, Jennische E, Lönnroth I: Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa. FEBS Lett. 2004, 561: 122-126. 10.1016/S0014-5793(04)00139-5.CrossRefPubMed
21.
go back to reference Sartor RB: Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006, 3: 390-407. 10.1038/ncpgasthep0528.CrossRefPubMed Sartor RB: Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006, 3: 390-407. 10.1038/ncpgasthep0528.CrossRefPubMed
22.
go back to reference Desai D, Faubion WA, Sandborn WJ: Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther. 2007, 25 (3): 247-55.CrossRefPubMed Desai D, Faubion WA, Sandborn WJ: Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther. 2007, 25 (3): 247-55.CrossRefPubMed
23.
go back to reference Morrison AC, Wilson CB, Ray M, Correll PH: Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol. 172: 1825-1832. 2004, Feb 1 Morrison AC, Wilson CB, Ray M, Correll PH: Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol. 172: 1825-1832. 2004, Feb 1
Metadata
Title
Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study
Authors
Anders Eriksson
Carl-Fredrik Flach
Anders Lindgren
Eva Kvifors
Stefan Lange
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2008
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-8-34

Other articles of this Issue 1/2008

BMC Gastroenterology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine